个人简述:

张峻颖，女，副教授，硕士研究生导师，日本国立千叶大学药学博士。主要从事药物制剂新剂型与新工艺的研究，具体为1）纳米载体的核磁共振研究；2）糖基化中药新辅料的开发。2012年回国后已主持了两项国家自然科学基金、一项人社部留学回国人员科技活动择优资助项目、两项中央高校基本科研基金及多项横向课题，在国内外核心刊物及SCI期刊已发表论文几十篇。

科研工作:

代表性论文：1、J. Zhang, K. Higashi, Y. Tozuka, et.al.. Drug solubilization mechanism of a-glucosyl stevia by NMR spectroscopy. Int. J. Pharm. , 465(1-2):255-261 (2014). (IF: 3.785)2、Chunyong W, Xue X, Chao F, Yuanyuan S, Wenyuan L, Xiaoyun Z, J. Zhang *. Degradation kinetics study of cabozantinib by a novelstability-indicating LC method and identification of its majordegradation products by LC/TOF-MS and LC–MS/MS. J. Pharmaceut. Biomed., 98:356–363(2014). (IF: 2.829)3、J. Zhang, K. Higashi, W. Limwikrant, et.al.. Molecular-level characterization of probucol nanocrystal in water by in situ solid-state NMR spectroscopy. Int. J. Pharm. , 423:571–576(2012). (IF: 3.458)4、J. Zhang, Y. Tozuka, H. Uchiyama,et.al.. NMR investigation of a novel excipient, α-glucosylhesperidin, as a suitable solubilizing agent for poorly water-soluble drugs. J. Pharm. Sci., 100:4421–4431(2011). (IF: 3.055)5、K. Moribe, M. Masaki, R. Kinoshita, J. Zhang, et.al.. Guest molecular size-dependent inclusion complexation of parabens with cholic acid by cogrinding. Int. J. Pharm., 420:191–197(2011). (IF: 3.607)6、Y. Tozuka, K. Higashi, T. Morita, H. Uchiyama, J. Zhang, et.al.. Transglycosylated rutin induced non-surface active nanostructure for absorption enhancement of flurbiprofen. Eur J Pharm Biopharm, 82(1), 120-126, (2012) (IF: 4.304)